Identifying the Target Traumatic Brain Injury Population for Hyperbaric Oxygen Therapy

Area of Science:

• Neuroscience
• Hyperbaric Medicine
• Trauma Research

Background:

• Traumatic brain injury (TBI) affects millions annually, with secondary injury exacerbating primary damage.
• Inflammation is a key factor in secondary brain injury following TBI.
• Hyperbaric oxygen therapy (HBOT) is an established wound treatment being explored for TBI.

Purpose of the Study:

• To review preclinical and clinical studies on HBOT for TBI.
• To investigate the mechanisms of HBOT's therapeutic effects in TBI.
• To assess the clinical potential and safety of HBOT for TBI patients.

Main Methods:

• Review of recent preclinical and clinical studies on HBOT and TBI.
• Examination of identified molecular pathways (e.g., TLR4/NF-kB).
• Analysis of clinical data on HBOT safety and efficacy in TBI patients.

Main Results:

• HBOT increases brain oxygenation and reduces inflammation, apoptosis, intracranial pressure, and edema.
• Preclinical studies suggest HBOT affects pathways like TLR4/NF-kB.
• Clinical studies indicate HBOT is safe and improves neurological function in TBI patients.

Conclusions:

• HBOT is a promising therapeutic strategy for TBI.
• Further research into HBOT mechanisms is warranted.
• HBOT demonstrates significant clinical potential for TBI treatment.